How are ALGN straddle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the ALGN straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 40.56%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,457.07 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a ALGN straddle?

The breakeven for the ALGN straddle priced on this page is roughly $145.40 and $174.60 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ALGN market-implied 1-standard-deviation expected move is approximately 11.63%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current ALGN implied volatility affect this straddle?

ALGN ATM IV is at 40.56% with IV rank near 24.29%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

ALGN Straddle Strategy

ALGN (Align Technology, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan.

ALGN (Align Technology, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $11.58B, a trailing P/E of 26.87, a beta of 1.70 versus the broader market, a 52-week range of 122-208.31, average daily share volume of 1.2M, a public-listing history dating back to 2001, approximately 21K full-time employees. These structural characteristics shape how ALGN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.70 indicates ALGN has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a straddle on ALGN?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

Current ALGN snapshot

As of May 15, 2026, spot at $157.59, ATM IV 40.56%, IV rank 24.29%, expected move 11.63%. The straddle on ALGN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.

Why this straddle structure on ALGN specifically: ALGN IV at 40.56% is on the cheap side of its 1-year range, which favors premium-buying structures like a ALGN straddle, with a market-implied 1-standard-deviation move of approximately 11.63% (roughly $18.33 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ALGN expiries trade a higher absolute premium for lower per-day decay. Position sizing on ALGN should anchor to the underlying notional of $157.59 per share and to the trader's directional view on ALGN stock.

ALGN straddle setup

The ALGN straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ALGN near $157.59, the first option leg uses a $160.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ALGN chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ALGN shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$160.00	$6.35
Buy 1	Put	$160.00	$8.25

ALGN straddle risk and reward

Net Premium / Debit: -$1,460.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$1,457.07
Breakeven(s): $145.40, $174.60
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

ALGN straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on ALGN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$14,539.00
$34.85	-77.9%	+$11,054.71
$69.70	-55.8%	+$7,570.42
$104.54	-33.7%	+$4,086.13
$139.38	-11.6%	+$601.83
$174.22	+10.6%	-$37.54
$209.07	+32.7%	+$3,446.75
$243.91	+54.8%	+$6,931.04
$278.75	+76.9%	+$10,415.33
$313.60	+99.0%	+$13,899.62

When traders use straddle on ALGN

Straddles on ALGN are pure-volatility plays that profit from large moves in either direction; traders typically buy ALGN straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

ALGN thesis for this straddle

The market-implied 1-standard-deviation range for ALGN extends from approximately $139.26 on the downside to $175.92 on the upside. A ALGN long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current ALGN IV rank near 24.29% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ALGN at 40.56%. As a Healthcare name, ALGN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ALGN-specific events.

ALGN straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ALGN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ALGN alongside the broader basket even when ALGN-specific fundamentals are unchanged. Always rebuild the position from current ALGN chain quotes before placing a trade.

Frequently asked questions

What is a straddle on ALGN?: A straddle on ALGN is the straddle strategy applied to ALGN (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With ALGN stock trading near $157.59, the strikes shown on this page are snapped to the nearest listed ALGN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are ALGN straddle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the ALGN straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 40.56%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,457.07 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ALGN straddle?: The breakeven for the ALGN straddle priced on this page is roughly $145.40 and $174.60 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ALGN market-implied 1-standard-deviation expected move is approximately 11.63%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on ALGN?: Straddles on ALGN are pure-volatility plays that profit from large moves in either direction; traders typically buy ALGN straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current ALGN implied volatility affect this straddle?: ALGN ATM IV is at 40.56% with IV rank near 24.29%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.